Disruption of latent TGF-β binding protein (LTBP)–4 expression in the mouse leads to abnormal lung development and colorectal cancer. Lung fibroblasts from these mice produced decreased amounts of active TGF-β, whereas secretion of latent TGF-β was significantly increased. Expression and secretion of TGF-β2 and -β3 increased considerably. These results suggested that TGF-β activation but not secretion would be severely impaired in LTBP-4 −/− fibroblasts. Microarrays revealed increased expression of bone morphogenic protein (BMP)–4 and decreased expression of its inhibitor gremlin. This finding was accompanied by enhanced expression of BMP-4 target genes, inhibitors of differentiation 1 and 2, and increased deposition of fibronectin-rich extracellular matrix. Accordingly, increased expression of BMP-4 and decreased expression of gremlin were observed in mouse lung. Transfection of LTBP-4 rescued the −/− fibroblast phenotype, while LTBP-1 was inefficient. Treatment with active TGF-β1 rescued BMP-4 and gremlin expression to wild-type levels. Our results indicate that the lack of LTBP-4–mediated targeting and activation of TGF-β1 leads to enhanced BMP-4 signaling in mouse lung.
Skip Nav Destination
Article navigation
11 October 2004
Article Contents
Article|
October 04 2004
Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung
Katri Koli,
Katri Koli
1Department of Virology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
2Department of Pathology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Frank Wempe,
Frank Wempe
3Laboratory for Molecular Hematology, University of Frankfurt Medical School, 60596 Frankfurt am Main, Germany
Search for other works by this author on:
Anja Sterner-Kock,
Anja Sterner-Kock
3Laboratory for Molecular Hematology, University of Frankfurt Medical School, 60596 Frankfurt am Main, Germany
4Institute of Veterinary Pathology, Freie University, 14163 Berlin, Germany
Search for other works by this author on:
Anna Kantola,
Anna Kantola
1Department of Virology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
2Department of Pathology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Martina Komor,
Martina Komor
5Department of Hematology/Oncology, University Hospital, 60596 Frankfurt am Main, Germany
Search for other works by this author on:
Wolf-K. Hofmann,
Wolf-K. Hofmann
5Department of Hematology/Oncology, University Hospital, 60596 Frankfurt am Main, Germany
Search for other works by this author on:
Harald von Melchner,
Harald von Melchner
3Laboratory for Molecular Hematology, University of Frankfurt Medical School, 60596 Frankfurt am Main, Germany
Search for other works by this author on:
Jorma Keski-Oja
Jorma Keski-Oja
1Department of Virology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
2Department of Pathology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
Search for other works by this author on:
Katri Koli
1Department of Virology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
2Department of Pathology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
Frank Wempe
3Laboratory for Molecular Hematology, University of Frankfurt Medical School, 60596 Frankfurt am Main, Germany
Anja Sterner-Kock
3Laboratory for Molecular Hematology, University of Frankfurt Medical School, 60596 Frankfurt am Main, Germany
4Institute of Veterinary Pathology, Freie University, 14163 Berlin, Germany
Anna Kantola
1Department of Virology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
2Department of Pathology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
Martina Komor
5Department of Hematology/Oncology, University Hospital, 60596 Frankfurt am Main, Germany
Wolf-K. Hofmann
5Department of Hematology/Oncology, University Hospital, 60596 Frankfurt am Main, Germany
Harald von Melchner
3Laboratory for Molecular Hematology, University of Frankfurt Medical School, 60596 Frankfurt am Main, Germany
Jorma Keski-Oja
1Department of Virology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
2Department of Pathology, Haartman Institute and Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland
Correspondence to Katri Koli: [email protected]
Abbreviations used in this paper: BMP, bone morphogenic protein; CTGF, connective tissue growth factor; GADPH, glyceraldehyde-3-phosphate dehydrogenase; Id, inhibitor of differentiation; LTBP, latent TGF-β binding protein; MMP, matrix metalloproteinase; PAI-1, plasminogen activator inhibitor-1; wt, wild-type.
Received:
March 10 2004
Accepted:
August 04 2004
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2004
J Cell Biol (2004) 167 (1): 123–133.
Article history
Received:
March 10 2004
Accepted:
August 04 2004
Citation
Katri Koli, Frank Wempe, Anja Sterner-Kock, Anna Kantola, Martina Komor, Wolf-K. Hofmann, Harald von Melchner, Jorma Keski-Oja; Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung . J Cell Biol 11 October 2004; 167 (1): 123–133. doi: https://doi.org/10.1083/jcb.200403067
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement